DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
November 21, 2020
11 AM – 1:30 PM PST
Through 3 separate talks, this seminar series will focus on the medical (neurological/developmental), neuropsychological, behavioral, and educational aspects of the neurocognitive complications of sickle cell disease to raise awareness in patients and providers about these challenges.
Our goal is to help raise awareness about the neurocognitive challenges associated with sickle cell disease so that patients, parents, and their families will be able to recognize these issues earlier in life, actively discuss their concerns with their providers in an informed manner, and advocate for necessary treatments and services.
You will learn:
- The role of executive function in child and adult development
- Why and how sickle cell disease can impact executive function
- Diagnostic and treatment options available for executive dysfunction
- Cognitive challenges associated with sickle cell disease, such as ADHD, learning disabilities, and language disorders
We look forward to having you join us during these mini-seminars. Mark your calendars for the others taking place in 2021:
- Saturday, March 20, 2021 from 11 am – 1:30 pm PST
- Saturday, May 22, 2021 from 11 am – 1 pm PST
This event has ended.
education & researchCognitive function, coping, and depressive symptoms in children and adolescents with sickle cell diseaseOBJECTIVE: The objective of this study ...
people & placesPatrick Woster, PhDPatrick M. Woster is professor of drug d...
education & researchChronic Opioid Therapy and Central Sensitization in Sickle Cell DiseaseChronic opioid therapy (COT) for chronic...
people & placesClayton Andrews, LAPCClayton Andrews is a 35-year-old patient...
news & eventsEmmaus, a leader in sickle cell disease treatment, signs agreement with Cardinal Health to solidify distribution net...Emmaus Life Sciences, Inc. announces...
Community CenterToday’s Faces of Sickle Cell Disease: Deidra Flowers-WilliamsAt six months of age, Deidra Flowers-Wil...
videos & visualsPatient Perspective: The Journey of Pain in Sickle Cell Diseasehttps://www.youtube.com/watch?v=F4raFO0e...
send a message
Don’t forget to join the oneSCDvoice community!
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.